Demonstrates the ability to localize HCV RNA in the cytoplasm of hepatocytes using non-radioactive in situ hybridization in patients with chronic NANB hepatitis.
Answers are grounded in this paper and cite their sources.
Enables tissue-level HCV detection in seropositive patients; leaves open standardization and clinical adoption of in situ hybridization.
Localization of hepatitis C virus (HCV) RNA was investigated by non-radioactive in situ hybridization in human liver specimens of chronic non-A, non-B (NANB) hepatitis patients who were seropositive for antibodies to HCV (anti-HCV). For in situ hybridization, T-T dimerized synthetic oligodeoxynucleotide probes were used and DNAs hybridized in situ were detected immunohistochemically using specific antibodies against T-T dimer. The data demonstrates that HCV-RNA was localized in the cytoplasm of hepatocytes in human liver biopsies obtained from the patients with chronic NANB hepatitis seropositive for anti-HCV.
No takes yet. Share an insight, caveat, or question.
Yamada et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: